26 December 2018 - The United
States Cough Medicine Market displayed strong growth in assessment years.
The market is dominated by oral syrups that take the lead in most acceptable
forms of treatment due to its pleasant taste and ease of ingestion. The oral
syrups cough medicine segment remained boisterous dominating cough medicine
market and will portray attractive forecast period.
Liquid
dosage forms have always held sway over other dosage forms as administration
method especially with paediatric and aging people. This was attributed to
major medicines in cough therapy being sold as having higher penetration as
oral syrups in Cough Medicine. This adoption of oral syrups by pharmacy chains
will hold market steady in sales of oral syrups in United States Cough Medicine
industry.
The
growth factors for United States Cough Medicine Market is the attractiveness
that oral syrup holds for patients belonging to all age groups and oral syrups
are the favoured medication for most children and geriatric people undermining
growth of United States Cough Medicine Industry. North America is a big market
for oral syrups in forecast period. This is more pronounced because North
America possesses a clear majority in doses type segment in revenue terms in
preceding year and will be more so in the near future.
Oral
syrups are witnessing an upward trend in sales by doses type in United States
cough segment market and will consolidate on market strength in forecast years.
An attractive index of 1.5 speaks highly of itself in support of United States
Cough Medicine Market. Exception to market growth will be the attention that
children are receiving in administration of syrups brought over the counter
(OTC) causing market recall of large amount of cough syrups having undesirable
quantities of hydrocodone.
Latin
America is way ahead of market projections in oral syrups segment and will
dominate sales forecast in coming years. Segmentation of United States Cough
Medicine Market includes tablet, oral and others. Segmentation of United States
Cough Medicine Industry includes hospital, clinic, medical center and others.
The key industries in United States Cough medicine market include
GlaxoSmithKline, Pfizer, Sanofi, Merck and Novartis.
Market Segment:
Geographically, this report splits the
United States market into seven regions:
•
The West
•
Southwest
•
The Middle Atlantic
•
New England
•
The South
•
The Midwest
with
sales (volume), revenue (value), market share and growth rate of Cough Medicine
in these regions, from 2013 to 2025 (forecast).
United States Cough Medicine market
competition by top manufacturers/players, with Cough Medicine sales volume,
price, revenue (Million USD) and market share for each manufacturer/player; the
top players including
•
Pfizer
•
GlaxoSmithKline
•
Sanofi
•
Merck
•
Novartis
Comments
Post a Comment